PREVALENSI TINGKAT KECEMASAN PADA PASIEN KANKER PAYUDARA YANG MENJALANI KEMOTERAPI DI RSUP PROF.DR. I.G.N.G NGOERAH TAHUN 2023

Authors

  • NI KETUT PUTRI ARIANI Departemen/KSM Psikiatri, Fakultas Kedokteran, Universitas Udayana RSUP Prof. Dr. I.G.N.G Ngoerah, Denpasar
  • COKORDA BAGUS JAYA LESMANA Departemen/KSM Psikiatri, Fakultas Kedokteran, Universitas Udayana RSUP Prof. Dr. I.G.N.G Ngoerah, Denpasar
  • AMITA ROULI PURNAMA SITANGGANG Departemen/KSM Psikiatri, Fakultas Kedokteran, Universitas Udayana RSUP Prof. Dr. I.G.N.G Ngoerah, Denpasar
  • REBECCA MUTIA AGUSTINA SILAEN Departemen/KSM Psikiatri, Fakultas Kedokteran, Universitas Udayana RSUP Prof. Dr. I.G.N.G Ngoerah, Denpasar
  • HERMAN YOSEF Departemen/KSM Psikiatri, Fakultas Kedokteran, Universitas Udayana RSUP Prof. Dr. I.G.N.G Ngoerah, Denpasar

DOI:

https://doi.org/10.51878/paedagogy.v4i1.2758

Keywords:

cemas, kanker payudara, kemoterapi, psikiatri

Abstract

The level of anxiety in breast cancer patients undergoing chemotherapy poses a risk of unfavorable outcomes. Based on data collected in 2019 from three electronic databases (PubMed, Web of Science, and Scopus), a total of 36 studies covering 16,298 breast cancer patients between 2000 and 2018 were included in the research. The prevalence of anxiety among breast cancer patients was 41.9% (CI: 95%), highlighting the significance of both psychological and physical factors in breast cancer patients. The objective of this study was to determine the prevalence of anxiety in breast cancer patients undergoing chemotherapy at Prof. Dr. I.G.N.G Ngoerah Hospital. This was an observational descriptive study with a cross-sectional design to assess the level of anxiety in breast cancer patients receiving chemotherapy in the hospital. Anxiety was measured using the Beck Anxiety Inventory (BAI). Out of the 42 participants in the study, it was found that 54.8% experienced minimal anxiety, 31.0% had mild anxiety, 9.5% had moderate anxiety, and 4.8% had severe anxiety. Patients with severe anxiety were mostly in the age range of 0-30 years (50%), had completed junior high school education (20%), were unemployed (5.6%), unmarried (20%), had comorbidities (5.6%), and received chemotherapy more than 10 times (20%).

ABSTRAK
Tingkat kecemasan pada pasien kanker payudara yang sedang melakukan kemoterapi berisiko pada terjadinya peningkatan kondisi yang tidak mengutungkan. Prevalensi kecemasan pada pasien kanker payudara berdasarkan data yang dikumpulkan pada tahun 2019 dari tiga database elektronik (PubMed, Web of Science, dan Scopus) sebanyak 36 penelitian yang mencakup 16.298 pasien kanker payudara antara tahun 2000 dan 2018 terdaftar dalam penelitian tersebut, prevalensi kecemasan di antara pasien kanker payudara adalah 41,9% (CI: 95%) menunjukkan pentingnya faktor psikologis serta fisik pada pasien kanker payudara. Tujuan dari penelitian ini adalah untuk mengetahui prevalensi kecemasan pada pasien kanker payudara yang sedang melakukan kemoterapi di RSUP Prof. Dr. I.G.N.G Ngoerah. Penelitian ini merupakan penelitian observasional deskriptif dengan rancangan cross-sectional untuk mengetahui tingkat kecemasan pada pasien kanker payudara yang melakukan kemoterapi di rumah sakit. Kecemasan diukur dengan pengukuran tingkat kecemasan menurut Beck Anxiety Inventory (BAI). Sebanyak 42 sampel yang mengikuti penelitian, didapatkan sebanyak 54,8% mengalami cemas minimal, 31,0% mengalami kecemasan ringan, 9,5% mengalami kecemasan sedang, dan 4,8% mengalami kecemasan berat. Pasien yang memiliki tingkat kecemasan berat sebagian besar adalah pada rentang umur 0-30 tahun (50%), tingkat pendidikan SMP (20%), tidak bekerja sebesar (5,6%), belum menikah (20%), dengan penyakit penyerta (5,6%), dan frekuensi kemoterapi >10 kali (20%)

Downloads

Download data is not yet available.

References

Abraham, N. and Kallivayalil, R., 2021. Anxiety, depression and quality of life in breast cancer patients undergoing chemotherapy in a tertiary care centre- a cross-sectional study. Kerala Journal of Psychiatry, [online] 34(2). Available at: https://doi.org/10.30834/KJP.34.2.2021.286

Alagizy, H.A., Soltan, M.R., Soliman, S.S., Hegazy, N.N. and Gohar, S.F., 2020. Anxiety, depression and perceived stress among breast cancer patients: single institute experience. Middle East Current Psychiatry, 27(1), pp.1-10.

Alkabban, F. and Ferguson, T., 2022. Breast Cancer. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482286/

Aryanti, C., Setiawan, I. and Sudarsa, I., 2019. Profile of breast cancer epidemiology in Sanglah General Hospital, Denpasar, Bali from 2012 to 2019. Annals of Oncology, [online] 30, p.ix11. Available at: https://doi.org/10.1093/annonc/mdz417.007

Balaram, K. and Marwaha, R., 2022. Agoraphobia. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK554387/#_NBK554387_pubdet_

Boland, R., Verduin, M., Ruiz, P., Shah, A. and Sadock, B., 2022. Kaplan & Sadock's synopsis of psychiatry. 12th ed. philadephia: Wolters Kluwer, pp.688-707.

Chand, S. and Marwaha, R., 2022. Anxiety. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470361/#_NBK470361 pubdet

Civilotti, C., Botto, R., Maran, D.A., Leonardis, B.D., Bianciotto, B. and Stanizzo, M.R., 2021. Anxiety and depression in women newly diagnosed with breast cancer and waiting for surgery: prevalence and associations with socio-demographic variables. Medicina, 57(5), p.454.

Colleaga.org. 2022. Beck Anxiety Inventory | Colleaga. [online] Available at: https://www.colleaga.org/tools/beck-anxiety-inventory

Diagnostic and statistical manual of mental disorders. 2022. 5th ed. Washington: American psychiatric Association, pp.216-262.

Hashemi, S., Rafiemanesh, H., Aghamohammadi, T., Badakhsh, M., Amirshahi, M., Sari, M., Behnamfar, N. and Roudini, K., 2019. Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer, [online] 27(2), pp.166-178. Available at: https://doi.org/10.1007/s12282-019-01031-9

Hormozi, M., Hashemi, S.M. and Shahraki, S., 2019. Investigating relationship between pre-and post-chemotherapy cognitive performance with levels of depression and anxiety in breast cancer patients: A cross-sectional study. Asian Pacific Journal of Cancer Prevention: APJCP, 20(12), p.3831.

K, T., IV, P., D, M., A, V., M, K., S, Z. and EC, F., 2022. Assessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors. [online] PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/29938451/

Li, J., Gao, W., Yang, Q. and Cao, F., 2020. Perceived stress, anxiety, and depression in treatment?naïve women with breast cancer: a case?control study. Psycho-Oncology, [online] 30(2), pp.231-239. Available at: https://doi.org/10.1002/pon.5555

Momenimovahed, Z. and Salehiniya, H., 2019. <p>Epidemiological characteristics of and risk factors for breast cancer in the world</p>. Breast Cancer: Targets and Therapy, [online] Volume 11, pp.151-164. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462164/

Muskin, P., 2021. Anxiety Disorders. [online] American Psychiatric Association. Available at: https://psychiatry.org/patients-families/anxiety-disorders/what-are-anxiety-disorders

Nakamura, Z.M., Deal, A.M., Nyrop, K.A., Chen, Y.T., Quillen, L.J., Brenizer, T. and Muss, H.B., 2021. Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer. The Oncologist, 26(2), pp.147-156.

Prakash, K. and Saini, S., 2017. Effectiveness of yoga on anxiety, depression and stress level of breast cancer patients undergoing chemotherapy. International Journal of Research in Medical Sciences, [online] 6(1), p.74. Available at: http://dx.doi.org/10.18203/2320-6012.ijrms20175511

Ram, D. and Manjunatha, N., 2022. Panic disorder in general medical practice- A narrative review. Journal of Family Medicine and Primary Care, [online] 11(3), p.861. Available at: https://journals.lww.com/jfmpc/Fulltext/2022/03000/Panic_disorder_in_general_medical_practice__A.10.aspx

Rose, G. and Tadi, P., 2022. Social Anxiety Disorder. [online] Ncbi.nlm.nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK555890/#_NBK555890_pubdet_

Rutkowski, S., Czech, O., Wrzeciono, A., Kiper, P., Szczepa?ska-Gieracha, J. and Malicka, I., 2021. Virtual reality as a chemotherapy support in treatment of anxiety and fatigue in patients with cancer: A systematic review and meta-analysis and future research directions. Complementary Therapies in Medicine, [online] 61, p.102767. Available at: https://doi.org/10.1016/j.ctim.2021.102767

Sadock, B., Sadock, V. and Ruiz, P., 2017. Comprehensive Textbook of Psychiatry. 10th ed. New york: Wolters kluwer.p.4495

Stahl, S., 2021. Anxiety, Trauma, and Treatment. 5th ed. Cambridge: Cambridge University Press, pp.369-377

Soqia, J., Al-Shafie, M., Yakoub, L.A., Basheer, M.A., Alhomsi, D., Saadoun R., Saifo, M., 2022. Depression, anxiety and related factors among Syrian breast cancer patients: a cross?sectional study. BMC Psychiatry 22:796 .Available at: https://doi.org/10.1186/s12888-022-04469-y

Ströhle, A., Gensichen, J. and Domschke, K., 2018. The Diagnosis and Treatment of Anxiety Disorders. Deutsches Ärzteblatt international, (115), pp.611–620.

Vismara, M., Girone, N., Cirnigliaro, G., Fasciana, F., Vanzetto, S., Ferrara, L., Priori, A., D’Addario, C., Viganò, C. and Dell’Osso, B., 2020. Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview. Brain Sciences, 10(8), p.564.

Waks, A. and Winer, E., 2019. Breast Cancer Treatment. JAMA, [online] 321(3), p.288. Available at: https://pubmed.ncbi.nlm.nih.gov/30667505/

Downloads

Published

2024-03-09

How to Cite

ARIANI, N. K. P., LESMANA, C. B. J. ., SITANGGANG, A. R. P. ., SILAEN, R. M. A. ., & YOSEF, H. . (2024). PREVALENSI TINGKAT KECEMASAN PADA PASIEN KANKER PAYUDARA YANG MENJALANI KEMOTERAPI DI RSUP PROF.DR. I.G.N.G NGOERAH TAHUN 2023. PAEDAGOGY : Jurnal Ilmu Pendidikan Dan Psikologi, 4(1), 1-8. https://doi.org/10.51878/paedagogy.v4i1.2758

Issue

Section

Articles